Pharma Marketing Network

MARCH 25, 2023

In the highly competitive pharmaceutical industry, creating a strong brand identity can set companies apart and help them connect with their target audience. A strong brand identity can help increase recognition and loyalty, and ultimately drive sales. However, developing a strong brand identity in the pharmaceutical industry is a complex process that requires careful planning and execution.

Pharmaceutical 52

Pharmaceutical Healthcare Healthcare Patients 52

Pharmacy Times

MARCH 25, 2023

Vibhuti Arya, PharmD, MPH, FAPhA, explains how APhA as an organization is opening discourse among its members regarding unpacking and dismantling structural racism in the organization and in the profession at large.

26

26

Pharma Marketing Network

MARCH 25, 2023

Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. With the increase in competition, it has become essential for pharmaceutical companies to find the most effective methods of advertisement to reach their target audience. In this article, we will discuss the most effective types of advertisement in the pharmaceutical industry and provide examples and statistics to support our findings. 1.

Pharma 52

Pharma Food and Drug Administration Pharmaceutical Healthcare 52

Pharmacy Times

MARCH 25, 2023

Vibhuti Arya, PharmD, MPH, FAPhA, discusses the role of the individual in progressing structural and systemic changes in the pharmacy ecosystem.

Patients 26

Patients 26

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

MARCH 25, 2023

Specifically, non-opioids are often preferred for the management of subacute and chronic pain because of their safety profiles.

Safety 26

Safety Management 26